Past, Present and Future of Epigenetics in Adrenocortical Carcinoma

por Ettaieb, Madeleine, Kerkhofs, Thomas, van Engeland, Manon, Haak, Harm
Publicado 2020

MEXPRESS update 2019

por Koch, Alexander, Jeschke, Jana, Van Criekinge, Wim, van Engeland, Manon, De Meyer, Tim
Publicado 2019

Stromal Expression of Hypoxia Regulated Proteins Is an Adverse Prognostic Factor in Colorectal Carcinomas

por Cleven, Arjen H. G., van Engeland, Manon, Wouters, Bradly G., de Bruïne, Adriaan P.
Publicado 2007

The emerging role of GATA transcription factors in development and disease

por Lentjes, Marjolein HFM, Niessen, Hanneke EC, Akiyama, Yoshimitsu, de Bruïne, Adriaan P, Melotte, Veerle, van Engeland, Manon
Publicado 2016

Characteristics of triple-negative breast cancer

por de Ruijter, Tim C., Veeck, Jürgen, de Hoon, Joep P. J., van Engeland, Manon, Tjan-Heijnen, Vivianne C.
Publicado 2010

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study

por van Lanschot, Meta C. J., Carvalho, Beatriz, Coupé, Veerle M. H., van Engeland, Manon, Dekker, Evelien, Meijer, Gerrit A.
Publicado 2017

Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology

por Hughes, Laura A. E., Simons, Colinda C. J. M., van den Brandt, Piet A., van Engeland, Manon, Weijenberg, Matty P.
Publicado 2017

Investigation of sirtuin 1 polymorphisms in relation to the risk of colorectal cancer by molecular subtype

por Hrzic, Rok, Simons, Colinda C. J. M., Schouten, Leo J., van Engeland, Manon, Brandt, Piet van den, Weijenberg, Matty P.
Publicado 2020

Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review

por de Ruijter, Tim C., van der Heide, Frank, Smits, Kim M., Aarts, Maureen J., van Engeland, Manon, Heijnen, Vivianne C. G.
Publicado 2020

Methylation-Specific PCR Unraveled

por Derks, Sarah, Lentjes, Marjolein H. F. M., Hellebrekers, Debby M. E. I., de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Publicado 2004

Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review

por Draht, Muriel X. G., Goudkade, Danny, Koch, Alexander, Grabsch, Heike I., Weijenberg, Matty P., van Engeland, Manon, Melotte, Veerle, Smits, Kim M.
Publicado 2018

The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiolog...

por Weijenberg, Matty P., Hughes, Laura A. E., Bours, Martijn J. L., Simons, Colinda C. J. M., van Engeland, Manon, van den Brandt, Piet A.
Publicado 2013

Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II...

por Draht, Muriel X. G., Smits, Kim M., Jooste, Valérie, Tournier, Benjamin, Vervoort, Martijn, Ramaekers, Chantal, Chapusot, Caroline, Weijenberg, Matty P., van Engeland, Manon, Melotte, Veerle
Publicado 2016

Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study

por Simons, Colinda C. J. M., Schouten, Leo J., Godschalk, Roger W. L., van Engeland, Manon, van den Brandt, Piet A., van Schooten, Frederik J., Weijenberg, Matty P.
Publicado 2015

Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers

por Massen, Maartje, Lommen, Kim, Wouters, Kim A. D., Vandersmissen, Johan, van Criekinge, Wim, Herman, James G., Melotte, Veerle, Schouten, Leo J., van Engeland, Manon, Smits, Kim M.
Publicado 2022

Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas

por van der Vlugt, Manon, Carvalho, Beatriz, Fliers, Joelle, Montazeri, Nahid, Rausch, Christian, Grobbee, Esmée J, van Engeland, Manon, Spaander, Manon C W, Meijer, Gerrit A, Dekker, Evelien
Publicado 2022

Epigenetic Changes in Basal Cell Carcinoma Affect SHH and WNT Signaling Components

por Brinkhuizen, Tjinta, van den Hurk, Karin, Winnepenninckx, Véronique J. L., de Hoon, Joep P., van Marion, Ariënne M., Veeck, Jürgen, van Engeland, Manon, van Steensel, Maurice A. M.
Publicado 2012

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

por Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Publicado 2013

Gene Promoter Methylation in Endometrial Carcinogenesis

por Cornel, Karlijn M. C., Wouters, Kim, Van de Vijver, Koen K., van der Wurff, Anneke A. M., van Engeland, Manon, Kruitwagen, Roy F. P. M., Pijnenborg, Johanna M. A.
Publicado 2018

Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer

por van de Pol, Jeroen A. A., van den Brandt, Piet A., van Engeland, Manon, Godschalk, Roger W. L., van Schooten, Frederik-Jan, Hogervorst, Janneke G. F., Schouten, Leo J.
Publicado 2020